Header

UZH-Logo

Maintenance Infos

Evaluation of white blood cell count as a possible prognostic marker for oral cancer


Kruse, Astrid L; Luebbers, Heinz T; Grätz, Klaus W (2011). Evaluation of white blood cell count as a possible prognostic marker for oral cancer. Head & Neck Oncology, 3:13.

Abstract

INTRODUCTION: There seems to be increasing evidence that inflammation leads to cancer. For several cancers, an association with white blood cell (WBC) count has been reported. So far, no studies have been performed for cancer of the oral cavity and WBC. Therefore, the aim of the present study was to look at whether WBC count can be used as a prognostic marker for recurrence or metastases for oral cancer. MATERIAL AND METHODS: For 278 patients with oral cancer, the preoperative WBC count was compared with the clinicopathological information: age, gender, T-status, N-status, recurrence, metastases, follow-up time, and time till recurrence or metastases appeared. RESULTS: Out of 278 patients, 48 developed recurrence, 24 second tumors, 46 cervical metastases, and 14 distant metastases. The mean follow-up time was 35.97 months (range: 12-107 months). Significant Pearson correlation at the 0.05 level could be found for the T-status (0.046), but not for the N status (0.121). No significant correlation could be found between WBC count and the development of recurrence or metastases. CONCLUSION: In conclusion, our findings demonstrate that elevated WBC count does not seem to be a predictor for recurrence or for further metastases. Further research is recommended to investigate the WBC count in precancerous lesions and in HPV positive patients with oral SCC.

Abstract

INTRODUCTION: There seems to be increasing evidence that inflammation leads to cancer. For several cancers, an association with white blood cell (WBC) count has been reported. So far, no studies have been performed for cancer of the oral cavity and WBC. Therefore, the aim of the present study was to look at whether WBC count can be used as a prognostic marker for recurrence or metastases for oral cancer. MATERIAL AND METHODS: For 278 patients with oral cancer, the preoperative WBC count was compared with the clinicopathological information: age, gender, T-status, N-status, recurrence, metastases, follow-up time, and time till recurrence or metastases appeared. RESULTS: Out of 278 patients, 48 developed recurrence, 24 second tumors, 46 cervical metastases, and 14 distant metastases. The mean follow-up time was 35.97 months (range: 12-107 months). Significant Pearson correlation at the 0.05 level could be found for the T-status (0.046), but not for the N status (0.121). No significant correlation could be found between WBC count and the development of recurrence or metastases. CONCLUSION: In conclusion, our findings demonstrate that elevated WBC count does not seem to be a predictor for recurrence or for further metastases. Further research is recommended to investigate the WBC count in precancerous lesions and in HPV positive patients with oral SCC.

Statistics

Citations

4 citations in Web of Science®
4 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

67 downloads since deposited on 06 Feb 2013
17 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Center for Dental Medicine > Clinic for Cranio-Maxillofacial Surgery
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2011
Deposited On:06 Feb 2013 18:03
Last Modified:07 Dec 2017 18:28
Publisher:BioMed Central
ISSN:1758-3284
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1186/1758-3284-3-13
PubMed ID:21352591

Download

Download PDF  'Evaluation of white blood cell count as a possible prognostic marker for oral cancer'.
Preview
Content: Published Version
Language: English
Filetype: PDF
Size: 606kB
View at publisher
Licence: Creative Commons: Attribution 2.0 Generic (CC BY 2.0)